+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zidovudine"

From
HIV Clinical Trials Market - Global Forecast 2025-2032 - Product Thumbnail Image

HIV Clinical Trials Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
From
HIV Antivirals Market - Global Forecast 2025-2030 - Product Thumbnail Image

HIV Antivirals Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Lamivudine Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lamivudine Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
HIV Drugs Market Report 2025 - Product Thumbnail Image

HIV Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Zidovudine, also known as AZT, is an antiretroviral drug used to treat HIV/AIDS and other immune disorders. It works by blocking the action of reverse transcriptase, an enzyme that helps HIV replicate. Zidovudine is usually taken in combination with other antiretroviral drugs to reduce the risk of drug resistance. It is also used to reduce the risk of mother-to-child transmission of HIV. Zidovudine is available in both oral and intravenous forms. It is usually taken once or twice daily, depending on the patient's condition. Common side effects include nausea, vomiting, headache, and fatigue. More serious side effects include anemia, liver damage, and pancreatitis. The zidovudine market is highly competitive, with many companies offering generic versions of the drug. Companies such as Cipla, Mylan, and Teva Pharmaceuticals are some of the major players in the market. Other companies include Aurobindo Pharma, Sun Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more